Loading...
Please wait, while we are loading the content...
Similar Documents
BRCA2 C-Terminal RAD51-Binding Domain Confers Resistance to DNA-Damaging Agents
| Content Provider | MDPI |
|---|---|
| Author | Zhu, Zida Kitano, Taisuke Morimatsu, Masami Tanaka, Arisa Morioka, Ryo Lin, Xianghui Orino, Koichi Yoshikawa, Yasunaga |
| Copyright Year | 2022 |
| Description | Breast cancer type 2 susceptibility (BRCA2) protein is crucial for initiating DNA damage repair after chemotherapy with DNA interstrand crosslinking agents or X-ray irradiation, which induces DNA double-strand breaks. BRCA2 contains a C-terminal RAD51-binding domain (CTRBD) that interacts with RAD51 oligomer-containing nucleofilaments. In this study, we investigated CTRBD expression in cells exposed to X-ray irradiation and mitomycin C treatment. Surprisingly, BRCA2 CTRBD expression in HeLa cells increased their resistance to X-ray irradiation and mitomycin C. Under endogenous BRCA2 depletion using shRNA, the sensitivities of the BRCA2-depleted cells with and without the CTRBD did not significantly differ. Thus, the resistance to X-ray irradiation conferred by an exogenous CTRBD required endogenous BRCA2 expression. BRCA2 CTRBD-expressing cells demonstrated effective RAD51 foci formation and increased homologous recombination efficiency, but not nonhomologous end-joining efficiency. To the best of our knowledge, our study is the first to report the ability of the BRCA2 functional domain to confer resistance to X-ray irradiation and mitomycin C treatment by increased homologous recombination efficiency. Thus, this peptide may be useful for protecting cells against X-ray irradiation or chemotherapeutic agents. |
| Starting Page | 4060 |
| e-ISSN | 14220067 |
| DOI | 10.3390/ijms23074060 |
| Journal | International Journal of Molecular Sciences |
| Issue Number | 7 |
| Volume Number | 23 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2022-04-06 |
| Access Restriction | Open |
| Subject Keyword | International Journal of Molecular Sciences Oncology Brca2 Dna Damage Repair Homologous Recombination Repair C-terminal Rad51-binding Domain X-ray Irradiation Mitomycin C |
| Content Type | Text |
| Resource Type | Article |